Gardasil 9

Human papillomavirus vaccine, 9-valent · Merck & Co.

Drug timelines are a Plus or Pro feature.

42 regulatory and trial events tracked for Gardasil 9, covering 2013-08-14 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia [Phase 2]

See pricing